Munetaka Takekuma

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 20

Top Topics

Prognostic Factors

Top Venues

Journal of gynecologic oncology

Japanese journal of radiology

This page only lists publications with an associated author ORCID identifier.

Publications

Munetaka Takekuma
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications. Journal of gynecologic oncology 35 (2) (2024)
Munetaka Takekuma
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications. Journal of gynecologic oncology 35 (2) (2024)
Noriyuki Okonogi, Keisuke Tsuchida, Ken Ando, Tatsuya Ohno, Hiroyuki Fujiwara, Kosuke Yoshihara, Takuya Aoki, Hirokuni Takano, Munetaka Takekuma, Aikou Okamoto, Shin Nishio
Significance of definitive concurrent chemoradiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study. Japanese journal of radiology 42 (7) (2024)
Munetaka Takekuma
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications. Journal of gynecologic oncology 35 (2) (2024)
Noriyuki Okonogi, Keisuke Tsuchida, Ken Ando, Tatsuya Ohno, Hiroyuki Fujiwara, Kosuke Yoshihara, Takuya Aoki, Hirokuni Takano, Munetaka Takekuma, Aikou Okamoto, Shin Nishio
Significance of definitive concurrent chemoradiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study. Japanese journal of radiology 42 (7) (2024)
Daisuke Aoki, Tsutomu Tabata, Satoshi Yanagida, Toshiaki Nakamura, Asumi Okumura, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, Shinichi Komiyama, Motoki Matsuura, Hidekatsu Nakai, Hiroko Nakamura, Jun Sakata, Kazuhiro Takehara, Munetaka Takekuma, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Junpei Soeda, Ai Kato, Ajit Suri, Aikou Okamoto, Toru Sugiyama
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study. Journal of gynecologic oncology 35 (5) (2024)
Noriyuki Okonogi, Keisuke Tsuchida, Ken Ando, Tatsuya Ohno, Hiroyuki Fujiwara, Kosuke Yoshihara, Takuya Aoki, Hirokuni Takano, Munetaka Takekuma, Aikou Okamoto, Shin Nishio
Significance of definitive concurrent chemoradiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study. Japanese journal of radiology (2024)
Noriyuki Okonogi, Keisuke Tsuchida, Ken Ando, Tatsuya Ohno, Hiroyuki Fujiwara, Kosuke Yoshihara, Takuya Aoki, Hirokuni Takano, Munetaka Takekuma, Aikou Okamoto, Shin Nishio
Significance of definitive concurrent chemoradiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study. Japanese journal of radiology 42 (7) (2024)
Munetaka Takekuma
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications. Journal of gynecologic oncology 35 (2) (2024)
Munetaka Takekuma
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications. Journal of gynecologic oncology 35 (2) (2024)
Munetaka Takekuma, Koji Matsuo, Shinya Matsuzaki, Mitsuya Ishikawa, Toyomi Satoh
Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors. Journal of gynecologic oncology (2024)
Ayumi Taguchi, Kosuke Kato, Konan Hara, Akiko Furusawa, Yujiro Nakajima, Chihiro Ishizawa, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori, Muneaki Shimada, Aikou Okamoto, Munetaka Takekuma
Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate-risk group. Cancer medicine (2023)
Nobutaka Takahashi, Munetaka Takekuma
Current trends in chemotherapy for advanced ovarian cancer. Japanese journal of clinical oncology 52 (8) (2022)
Shin Nishio, Kan Yonemori, Tomoka Usami, Shinichiro Minobe, Mayu Yunokawa, Takashi Iwata, Aikou Okamoto, Yoichi Aoki, Hiroaki Itamochi, Munetaka Takekuma, Kenichi Harano, Keiko Yamamoto, Takeshi Maruko, Hiroyuki Ugai, Cumhur Tekin, Nicoletta Colombo, Keiichi Fujiwara, Kosei Hasegawa, Kimio Ushijima
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826. Cancer science 113 (11) (2022)
Munetaka Takekuma, Fumiaki Takahashi, Seiji Mabuchi, Wataru Kudaka, Koji Horie, Mariko Ikeda, Ayumi Shikama, Akira Mitsuhashi, Shoji Nagao, Shiro Suzuki, Mika Mizuno, Shin Nishio, Hideki Tokunaga, Yukinobu Ota, Takahiro Kasamatsu, Ryo Kitagawa, Takafumi Toita, Hiroaki Kobayashi, Mitsuya Ishikawa, Nobuo Yaegashi
Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy. BMC cancer 20 (1) (2020)
Aikou Okamoto, Asumi Okumura, Toshiaki Nakamura, Satoshi Yanagida, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, Shinichi Komiyama, Motoki Matsuura, Hidekatsu Nakai, Hiroko Nakamura, Jun Sakata, Tsutomu Tabata, Kazuhiro Takehara, Munetaka Takekuma, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Junpei Soeda, Ajit Suri, Daisuke Aoki, Toru Sugiyama
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer. Journal of gynecologic oncology 32 (2) (2020)
Koji Matsuo, Malcolm Strachan Ross, Mayu Yunokawa, Marian S Johnson, Hiroko Machida, Kohei Omatsu, Merieme M Klobocista, Dwight D Im, Shinya Sato, Tsukasa Baba, Yuji Ikeda, Stephen H Bush, Kosei Hasegawa, Erin A Blake, Munetaka Takekuma, Masako Shida, Masato Nishimura, Sosuke Adachi, Tanja Pejovic, Satoshi Takeuchi, Takuhei Yokoyama, Yutaka Ueda, Keita Iwasaki, Takahito M Miyake, Shiori Yanai, Tadayoshi Nagano, Tadao Takano, Mian Mk Shahzad, Frederick R Ueland, Joseph L Kelley, Lynda D Roman
Clinical utility of CA-125 in the management of uterine carcinosarcoma. Journal of gynecologic oncology 29 (6) (2019)
Munetaka Takekuma, Mototsugu Shimokawa, Shin Nishio, Hideo Omi, Tsutomu Tabata, Yuji Takei, Kaei Nasu, Yoshiyuki Takahashi, Shinji Toyota, Yoshikazu Ichikawa, Atsushi Arakawa, Fuminori Ito, Hiroshi Tsubamoto, Taisuke Mori, Yasuyuki Hirashima, Kimihiko Ito
Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for uterine cervical cancer with lymph node metastasis. Cancer science 109 (5) (2018)
Munetaka Takekuma, Keita Mori, Tetsuji Iida, Kazuko Kurihara, Motoaki Saitou, Hideki Tokunaga, Kei Kawana, Masae Ikeda, Toyomi Satoh, Toshiaki Saito, Etsuko Miyagi, Yutaka Nagai, Akiko Furusawa, Yoshiaki Kawano, Kouichiro Kawano, Tsutomu Tabata, Yukinobu Ota, Ryoji Hayase, Mikio Mikami, Toru Sugiyama
The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group. Cancer chemotherapy and pharmacology 80 (4) (2017)
Munetaka Takekuma, Yuka Kasamatsu, Nobuhiro Kado, Shiho Kuji, Aki Tanaka, Nobutaka Takahashi, Masakazu Abe, Yasuyuki Hirashima
Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy. International journal of clinical oncology 21 (4) (2016)